Kostygina Ganna, England Lucinda, Ling Pamela
At the time of study, Ganna Kostygina and Pamela Ling were with the Center for Tobacco Control Research and Education and the Division of General Internal Medicine, Department of Medicine, University of California, San Francisco. Lucinda England was with the Centers for Disease Control and Prevention, Atlanta, GA.
Am J Public Health. 2016 Jul;106(7):1219-22. doi: 10.2105/AJPH.2016.303057. Epub 2016 Apr 14.
Tobacco companies have begun to acquire pharmaceutical subsidiaries and recently started to market nicotine replacement therapies, such as Zonnic nicotine gum, in convenience stores. Conversely, tobacco companies are producing tobacco products such as tobacco chewing gum and lozenges that resemble pharmaceutical nicotine replacement products, including a nicotine pouch product that resembles snus pouches. This convergence of nicotine and tobacco product marketing has implications for regulation and tobacco cessation.
烟草公司已开始收购制药子公司，最近还开始在便利店销售尼古丁替代疗法产品，如佐尼克尼古丁口香糖。相反，烟草公司正在生产烟草咀嚼胶和含片等烟草制品，这些制品类似于制药尼古丁替代产品，包括一种类似鼻烟袋的尼古丁袋产品。尼古丁与烟草产品营销的这种融合对监管和戒烟具有影响。
